P327 Effect of some anthraquinones on trabecular and subchondral bone in an experimental animal model  by unknown
Osteoarthrit is and Carti lage Vol.  13, Supp lement  A $161 
P325 
ORALLY ADMINISTERED ANABU TM (GIcNBu) PROTECTS 
JOINT SURFACES IN STREPTOCOCCAL CELL WALL 
ANTIGEN (SCW)-INDUCED ARTHRITIS IN LEWIS RATS 
TP Anastassiades 1 , M Grynpas 2, J Carran 1 , X Wang 2, A 
Cherian 2 
1Medicine, Biochemistry, Queen's University, Kingston, ON, 
Canada; 2Mount Sinai Hospital, Toronto, ON, Canada 
In previous work we had shown that GIcNBu (N-butyryl glu- 
cosamine) decreases the inflammation of SCW arthritis and in- 
creases BMD in this model. This investigation explores the effects 
of GIcNBu on bone loss. 
Chronic SCW arthritis was induced in female rats by a single IP 
injection. The Groups studied were: (a) no arthritis, no treatment; 
(b) arthritis, no treatment; (c) arthritis, GIcNBu 20mg/kg/day; (d) 
arthritis, GIcNBu 200mg/kg/day. The removed left tibiae were 
scanned using micro computed tomography to qualitatively and 
quantitatively measure the GIcNBu dosage effects on bone archi- 
tectu re. 
Isosurfaces generated from the scans show progressively less 
bone erosion with increasing dosages of GIcNBu.(Figure). Tra- 
becular bone volume, number and thickness, and subchondral 
plate thickness increased with GIcNBu dosage, so that Group (d) 
was similar to Group (a). Significant increases occurred predom- 
inantly in the lateral epiphysis and the metaphysis of the high 
dose group. The structure model index values decreased sig- 
nificantly (p=0.030) in the metaphysis from the untreated SCW- 
induced group to the high dose group, indicating a less rod-like 
trabecular structure. Strut analysis showed a significant increase 
(p =0.034) in the length of node to node struts from the untreated 
SCW-induced group to the high dose group on the medial side of 
the proximal epiphysis. 
Fig. 1. Isosurfaces of proximal rat tibia (a) No arthritis, no treatment; (b) 
arthritis, no treatment; (c) arthritis + low dose GIcNBu; (d) arthritis + high 
dose GIcNBu. 
The results indicate a dose-dependent increase in bone connec- 
tivity. The metaphyseal bone structure changes suggest that GIc- 
NBu functions systemically. Comparison of the isosurfaces and 
the architectural parameters studied in this investigation demon- 
strate that GIcNBu effectively protects bone from further erosion 
in this model of chronic inflammatory arthritis. 
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CHONDROITIN SULFATE EXERTS BENEFICIAL EFFECTS 
ON THE MECHANISMS LEADING TO OSTEOARTHRITIS 
SUBCHONDRAL BONE REMODELING 
J MarteI-Pelletier 1 , D Lajeunesse 1 , F Mineau 1 , P-A Vendittoli 2, J 
Verges 3, E Montell 3, J-P Pelletier 1 
10steoarthritis Research Unit, University of Montreal Hospital 
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2Department of Orthopaedics, Maisonneuve-Rosemont 
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Department, Bioiberica Farma, Barcelona, Spain 
Aim of study: In osteoarthritis (OA), the increased subchondral 
bone remodeling is associated with the development of cartilage 
lesions. These changes are related to an altered metabolism of 
the osteoblasts. The aim of this study was to determine the effect 
of chondroitin sulfate on the expression/production of the major 
osteoblast factors involved in the remodeling of human OA sub- 
chondral bone. 
Methods: The effect of chondroitin sulfate (200 i~g/ml) on human 
OA subchondral bone osteoblasts, before and after stimulation 
with vitamin D3 (1,25(OH)2D3; 50 nM), was measured on the ma- 
jor phenotypic factors, alkaline phosphatase, and osteocalcin; on 
the inflammatory mediators, IL-6 and COX-2; and on the bone 
remodeling factors, RANKL and OPG. 
Results: Data showed that the level of alkaline phosphatase ac- 
tivity upon stimulation by vitamin-D3 challenge, was increased by 
a 1.6-fold over basal values. Chondroitin sulfate did not affect 
basal and vitamin D3-induced alkaline phosphatase or osteocal- 
cin release. On the metabolic factors, chondroitin sulfate had no 
significant effect on IL-6, but significantly inhibited either basal 
or vitamin D3-stimulated COX-2. In the presence of vitamin D3, 
chondroitin sulfate upregulated OPG expression and production. 
On the protein level, chondroitin sulfate significantly increased 
OPG in both basal conditions and in the presence of vitamin D3. 
RANKL expression was almost abrogated with chondroitin sul- 
fate under basal conditions. Interestingly, under basal conditions, 
chondroitin sulfate significantly upregulated the expression ratio 
of OPG/RANKL. Vitamin D3 decreased this ratio, but chondroitin 
sulfate in the presence of vitamin D3 reversed this decrease. 
Conclusions: Our data indicate that chondroitin sulfate does not 
appear to overly affect cell integrity or osteoblast phenotypic cell 
markers. However, chondroitin sulfate by increasing the ratio of 
OPG/RANKL could exert a positive effect on OA subchondral 
bone structural changes, indicating a potential direct beneficial 
effect. Indeed, the expression of RANKL is increased in abnor- 
mal osteoblasts, thereby weighting the balance of OPG/RANKL 
toward bone destruction. Consequently, our data are of major sig- 
nificance as it is the ratio OPG/RANKL that dictates the magni- 
tude of osteoclastogenesis. These findings may help explain the 
mechanisms by which this drug could exert its effect on the pro- 
gression of OA structural changes. 
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EFFECT OF SOME ANTHRAQUINONES ON 
TRABECULAR AND SUBCHONDRAL BONE IN AN 
EXPERIMENTAL ANIMAL MODEL 
M Mian 1 , D Benetti 1 , R Aloisi 1 , A Conte 2, G Ronca 1 
11nterdipartimental Centre of Molecular and Clinical Genetics, 
University of Pisa, Pisa, Italy; 2Department of Agricultural 
Sciences, University of Modena and Reggio Emilia, Modena, 
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Aim of the Study: GR373, GR 375, and GR 377 are patented 
anthraquinone derivatives which are active on both cartilage and 
bone. The water soluble GR 373 (anthraquinone 2,6-disulfonic 
$162 Poster Presentat ions 
acid) resulted more active as a chondroprotector. The GR 375 
and GR 377, which are respectively the N,N-diethyl and diphene- 
tidin 2,6 disulfonamide derivatives of GR 373, are more active on 
bone. In this research we investigate the effect of GR 375 and GR 
377 on trabecular and subchondral bone in experimental animal. 
Methods: 18 female Wistar rats having a body weigth of 1804-10 
g were subjected to an experimentally-induced osteoporosis by 
surgically removing the ovaries. The animals were divided into 
three groups as follows: 1) control, 2) treated with GR 375 25 
mg/kg/os and 3) treated with GR 377 at the same dosage. Af- 
ter a three-month treatment period the rats were sacrificed and 
their posterior legs removed and stored in formalin solution at pH 
7.2. They were then dehydrated with warm methyl alcohol under 
vacuum and methyl methacrylate mbedded. Frontal 100 and 20- 
30 i~m thick sections of the specimens were prepared to evalu- 
ate the effect of treatment. Microradiographs of the femoral head 
and neck region were taken. The trabecular bone volume (%TBV) 
was measured histologically. The results indicate the treated an- 
imals (GR 377:54.53 4- 7.37, GR 375:49.48 4- 9.97) to have 
a greater %TBV when compared to the control group (41.32 4- 
4.54), nonetheless statistical significance was obtained only for 
the GR 377 treated group. Similar results were obtained after 
having assessed the tibial trabecular thickness. The subchondral 
and cortical components of bone were also markedly increased 
in the treated animals when compared to their control counter- 
parts.Bone density and mineralization are statistically higher in 
treated animals. 
Conclusion: 2,6 diphenetidine anthraquinone disulphonamide 
(GR 377) has been shown to be effective in increasing bone 
mass in the trabecular, subchondral and cortical components of 
bone in the ovariectomized rat. N,N' diethyl 2,6 anthraquinone 
disulphonamide (GR 375) was also shown to be effective, al- 
though not to the same extent as that of GR 377. Other studies 
have demonstrated these compounds to significantly decrease 
IL-6 and iNOS in LPS-challenged rats and to modulate the ex- 
pression of some proteins in bone metabolism and mineraliza- 
tion. The data suggest that one mechanism of GR 377 and GR 
375 action is the modulation of bone gene expression. 
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ORAL ADMINISTRATION OF ANABU TM (GIcNBu) TO 
OVARIECTOMIZED (OVX) RATS INCREASES BONE 
MINERAL DENSITY (BMD), LONG BONE GROWTH AND 
MODULATES GENE EXPRESSION IN THE LIVER 
TP Anastassiades X Yang, J Carran, K Rees-Milton, D Wainman 
Medicine, Queen's Universi~ Kingston, ON, Canada 
In previous studies, we had shown increased BMD in the long 
bones of an inlammatory arthritis model in the rat, by feeding 
GIcNBu (N-butyryl glucosamine). The aim of this study is to deter- 
mine if oral admininistration of GIcNBu affects BMD, bone growth 
and gene expression in the non-OVX and the OVX-rat model. 
Female Sprague Dawley rats were randomized into four Groups 
(8 animals each). In addition to their normal diet, the animals 
were fed on a daily basis (once a day), with either of GIcNBu 200 
mg/kg, or an equimolar amount of glucose (GIc) for 6 months. 
Groups 1,2, 3 and 4 were, respectively: GIc-fed, non-OVX, (Con- 
trol); GIcNBu-fed, non-OVX; GIc-fed, OVX; GIcNBu-fed, OVX. 
The BMD and body composition was measured by DXA (Ho- 
logic 4500, small animal software) every 2 months. At sacrifice (6 
months), femurs were removed for physical measurements. The 
total RNA from the liver was extracted (RNeasy Kit, Qiagen) and 
gene expression was assessed by microarray (rat 8K gene, flu- 
orescent Cy3 and Cy5), with Group 1 serving as the control for 
each of Groups 2-4. 
The results showed that there was increased length of femurs 
for Group 4 vs 3 and in femoral wet weights (trends), as well as 
for Group 2 vs 1 (Fig. 1). As expected, OVX led to increased 
body mass. The BMD of Group 4 femoral heads were higher than 
Group 3. Total body mineral content + lean body mass was also 
highest in Group 4. 
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Fig. 1. Effect of GIcNBu on femoral length (OVX and Controls). 
By microarray (all compared to Group 1), the number of regu- 
lated genes (> 2-fold) in the liver were: Group 2, 13; Group 3, 40; 
Group 4, 57. A small number of genes were highly regulated only 
in Group 3. 
We conclude that oral administration of GIcNBu results in en- 
hanced growth and increased BMD of femurs in the OVX rat. The 
microarray analysis (rat 8K gene chip) showed that a number of 
genes in the liver were remarkably regulated by GIcNBu. Compar- 
isons of the 4 experimental Groups suggest that GIcNBu feeding 
selectively regulates some genes post-ovariectomy. Since some 
of the selectively up-regulated genes in Group 4 encode for ciru- 
lating protein growth factors, we speculate that this may constitute 
a mechanism of action for the effects of GIcNBu on bone. 
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EXPRESSION OF HIF-I~ AND FACILITATIVE GLUCOSE 
TRANSPORTERS (GLUTs) IN NORMAL AND 
DEGENERATE HUMAN INTERVERTEBRAL DISCS 
JA Hoyland 1 , SM Richardson 1 , C Le Maitre 1 , AJ Freemont 1 , 
A Mobasheri 2 
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Aim of Study: Tissues such as cartilage and the intervertebral 
disc (IVD) are hypoxic and avascular and this affects glycolysis 
and cell metabolism. We have recently shown that human chon- 
drocytes express the hypoxia-inducible transcription factor alpha 
(H IF-1 ~), along with a number of facilitative glucose transporters 
including GLUT1, GLUT3 and GLUT9. Other groups have shown 
that cells from the rat nucleus pulposus (NP) express both GLUT1 
and H IF-1 ~, yet to date, no studies have identified the expression 
of HIF-I~ or other GLUTs in the human intervertebral disc. In this 
study we have used immunohistochemistry (IHC) to examine the 
expression of HIF-I~, GLUT1, GLUT3 and GLUT9 in normal and 
degenerate IVDs. 
Methods: Thirty-one paraffin-embedded human intervertebral 
disc biopsies were chosen for analysis. These included 10 non- 
degenerate and 21 degenerate discs. IHC was conducted using 
antibodies against HIF-I~, GLUT1, GLUT3 and GLUT9 and hu- 
man tissue microarrays erved as positive controls. 
Results: IHC confirmed that HIF-I~ and GLUTs 1, 3 and 9 pro- 
teins were all expressed in the normal human IVD. Expression 
